Fusogenic Alzheimer's peptide fragment Aβ (29-42) in interaction with lipid bilayers: Secondary structure, dynamics, and specific interaction with phosphatidyl ethanolamine polar heads as revealed by solid-state NMR

Protein Science

Volumn 14, Issue 5, 2005, Pages 1181-1189

  Ravault, Stéphanie ^a   Soubias, Olivier ^b   Saurel, Olivier ^b   Thomas, Annick ^a   Brasseur, Robert ^a   Milon, Alain ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

2H NMR; 31P NMR relaxation times; Alzheimer; Lipid dynamics; Membrane fusion; POPE

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; MUTANT PROTEIN; PEPTIDE FRAGMENT; PHOSPHATIDYLETHANOLAMINE;

ALZHEIMER DISEASE; ARTICLE; BETA SHEET; CARBOXY TERMINAL SEQUENCE; DEUTERON NUCLEAR MAGNETIC RESONANCE; HUMAN; LIPID BILAYER; LIPID COMPOSITION; OLIGOMERIZATION; PHASE TRANSITION; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTON NUCLEAR MAGNETIC RESONANCE; RELAXATION TIME; SOLID STATE; TRANSITION TEMPERATURE;

AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; LIPID BILAYERS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, SECONDARY;

EID: 17744391390     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.041291405     Document Type: Article

References (39)

1. Antzutkin, O.N. 2004. Amyloidosis of Alzheimer's Aβ peptides: Solid-state nuclear magnetic resonance, electron paramagnetic resonance, transmission electron microscopy, scanning transmission electron microscopy and atomic force microscopy studies. Magn. Reson. Chem. 42: 231-246.
2. Bokvist, M., Lindstrom, F., Watts, A., and Grobner, G. 2004. Two types of Alzheimer's β-amyloid (1-40) peptide membrane interactions: Aggregation preventing transmembrane anchoring versus accelerated surface fibril formation. J. Mol. Biol. 335: 1039-1049.
3. Bradshaw, J.P., Darkes, M.J., Harroun, T.A., Katsaras, J., and Epand, R.M. 2000. Oblique membrane insertion of viral fusion peptide probed by neutron diffraction. Biochemistry 39: 6581-6585.
4. Brasseur, R., Lins, L., Vanloo, B., Ruysschaert, J.M., and Rosseneu, M. 1992. Molecular modeling of the amphipathic helices of the plasma apolipoproteins. Proteins 13: 246-257.
5. Butterfield, D.A. and Kanski, J. 2002. Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid β-peptide 1-42. Peptides 23: 1299-1309.
6. Davis, J.H. 1983. The description of membrane lipid conformation, order and dynamics by 2H-NMR. Biochim. Biophys. Acta 737: 117-171.
7. Demeester, N., Baier, G., Enzinger, C., Goethals, M., Vandekerckhove, J., Rosseneu, M., and Labeur, C. 2000. Apoptosis induced in neuronal cells by C-terminal amyloid β-fragments is correlated with their aggregation properties in phospholipid membranes. Mol. Membr. Biol. 17: 219-228.
8. Dufourc, E.J., Mayer, C., Stohrer, J., Althoff, G., and Kothe, G. 1992. Dynamics of phosphate head groups in biomembranes. Comprehensive analysis using phosphorus-31 nuclear magnetic resonance lineshape and relaxation time measurements. Biophys. J. 61: 42-57.
9. Eckert, G.P., Kirsch, C., Leutz, S., Wood, W.G., and Muller, W.E. 2003. Cholesterol modulates amyloid β-peptide's membrane interactions. Pharmacopsychiatry 36: S136-143.
10. Epand, R.M. and Bottega, R. 1988. Determination of the phase behaviour of phosphatidylethanolamine admixed with other lipids and the effects of calcium chloride: Implications for protein kinase C regulation. Biochim. Biophys. Acta 944: 144-154.
11. Evin, G. and Weidemann, A. 2002. Biogenesis and metabolism of Alzheimer's disease Aβ amyloid peptides. Peptides 23: 1285-1297.
12. Ghosh, R. 1988. 31P and 2H NMR studies of structure and motion in bilayers of phosphatidylcholine and phosphatidylethanolamine. Biochemistry 27: 7750-7758.
13. Han, X., Bushweller, J.H., Cafiso, D.S., and Tamm, L.K. 2001. Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin. Nat. Struct. Biol. 8: 715-720.
14. Hardy, J. and Selkoe, D.J. 2002. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297: 353-356.
15. Ji, S.R., Wu, Y., and Sui, S.F. 2002. Cholesterol is an important factor affecting the membrane insertion of β-amyloid peptide (A β 1-40), which may potentially inhibit the fibril formation. J. Biol. Chem. 277: 6273-6279.
16. Kakio, A., Nishimoto, S.I., Yanagisawa, K., Kozutsumi, Y., and Matsuzaki, K. 2001. Cholesterol-dependent formation of GM1 ganglioside-bound amyloid β-protein, an endogenous seed for Alzheimer amyloid. J. Biol. Chem. 276: 24985-24990.
17. Kumar-Singh, S., Cras, P., Wang, R., Kros, J.M., van Swieten, J., Lubke, U., Ceuterick, C., Serneels, S., Vennekens, K., Timmermans, J.P., et al. 2002. Dense-core senile plaques in the Flemish variant of Alzheimer's disease are vasocentric. Am. J. Pathol. 161: 507-520.
18. Lin, H., Bhatia, R., and Lal, R. 2001. Amyloid β protein forms ion channels: Implications for Alzheimer's disease pathophysiology. FASEB J. 15: 2433-2444.
19. Lins, L., Charloteaux, B., Thomas, A., and Brasseur, R. 2001. Computational study of lipid-destabilizing protein fragments: Towards a comprehensive view of tilted peptides. Proteins 44: 435-447.
20. Mandal, P.K. and Pettegrew, J.W. 2004. Alzheimer's disease: NMR studies of asialo (GM1) and trisialo (GT1b) ganglioside interactions with Aβ(1-40) peptide in a membrane mimic environment. Neurochem. Res. 29: 447-453.
21. Martin, I., Dubois, M.C., Defrise-Quertain, F., Saermark, T., Burny, A., Brasseur, R., and Ruysschaert, J.M. 1994, Correlation between fusogenicity of synthetic modified peptides corresponding to the NH2-terminal extremity of simian immunodeficiency virus gp32 and their mode of insertion into the lipid bilayer: An infrared spectroscopy study. J. Virol. 68: 1139-1148.
22. Martin, I., Goormaghtigh, E., and Ruysschaert, J.M. 2003. Attenuated total reflection IR spectroscopy as a tool to investigate the orientation and tertiary structure changes in fusion proteins. Biochim. Biophys. Acta 1614: 97-103.
23. Mingeot-Leclercq, M.P., Lins, L., Bensliman, M., Van Bambeke, F., Van Der Smissen, P., Peuvot, J., Schanck, A., and Brasseur, R. 2002. Membrane destabilization induced by β-amyloid peptide 29-42: Importance of the amino-terminus. Chem. Phys. Lipids 120: 57-74.
24. Mingeot-Leclercq, M.P., Lins, L., Bensliman, M., Thomas, A., Van Bambeke, F., Peuvot, J., Schanck, A., and Brasseur, R. 2003. Piracetam inhibits the lipid-destabilising effect of the amyloid peptide Aβ C-terminal fragment. Biochim. Biophys. Acta 1609: 28-38.
25. Mo, Y., Cross, T.A., and Nerdal, W. 2004. Structural restraints and heterogeneous orientation of the gramicidin A channel closed state in lipid bilayers. Biophys. J. 86: 2837-2845.
26. Petkova, A.T., Ishii, Y., Balbach, J.J., Antzutkin, O.N., Leapman, R.D., Delaglio, F., and Tycko, R. 2002. A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl. Acad. Sci. 99: 16742-16747.
27. Pillot, T., Goethals, M., Vanloo, B., Talussot, C., Brasseur, R., Vandekerckhove, J., Rosseneu, M., and Lins, L. 1996. Fusogenic properties of the C-terminal domain of the Alzheimer β-amyloid peptide. J. Biol. Chem. 271: 28757-28765.
28. Pillot, T., Drouet, B., Queille, S., Labeur, C., Vandekerchkhove, J., Rosseneu, M., Pincon-Raymond, M., and Chambaz, J. 1999. The nonfibrillar amyloid β-peptide induces apoptotic neuronal cell death: Involvement of its C-terminal fusogenic domain. J. Neurochem. 73: 1626-1634.
29. Saito, H., Tuzi, S., Yamaguchi, S., Tanio, M., and Naito, A. 2000. Conformation and backbone dynamics of bacteriorhodopsin revealed by (IS)C-NMR. Biochim. Biophys. Acta 1460: 39-48.
30. Seelig, J., Gally, G.U., and Wohlgemuth, R. 1977. Orientation and flexibility of the choline head group in phosphatidylcholine bilayers. Biochim. Biophys. Acta 467: 109-119.
31. Sun, H., Sanders, L.K., and Oldfield, E. 2002. Carbon-13 NMR shielding in the twenty common amino acids: Comparisons with experimental results in proteins. J. Am. Chem. Soc. 124: 5486-5495.
32. Tashima, Y., Oe, R., Lee, S., Sugihara, G., Chambers, E.J., Takahashi, M., and Yamada, T. 2004. The effect of cholesterol and monosialoganglioside (GM1) on the release and aggregation of amyloid β-peptide from liposomes prepared from brain membrane-like lipids. J. Biol. Chem. 279: 17587-17595.
33. Terzi, E., Holzemann, G., and Seelig, J. 1997. Interaction of Alzheimer β-amyloid peptide(1-40) with lipid membranes. Biochemistry 36: 14845-14852.
34. Tycko, R. 2003. Insights into the amyloid folding problem from solid-state NMR. Biochemistry 42: 3151-3159.
35. _. 2004. Progress towards a molecular-level structural understanding of amyloid fibrils. Curr. Opin. Struct. Biol. 14: 96-103.
36. Van Bambeke, F., Tulkens, P.M., Brasseur, R., and Mingeot-Leclercq, M.P. 1995. Aminoglycoside antibiotics induce aggregation but not fusion of negatively-charged liposomes. Eur. J. Pharmacol. 289: 321-333.
37. Waschuk, S.A., Elton, E.A., Darabie, A.A., Fraser, P.E., and McLaurin, J.A. 2001. Cellular membrane composition defines A β-lipid interactions. J. Biol. Chem. 276: 33561-33568.
38. Wishart, D.S. and Sykes, B.D. 1994. The 13C chemical-shift index: A simple method for the identification of protein secondary structure using 13C chemical-shift data. J. Biomol. NMR 4: 171-180.
39. Xiaocui, M., Sha, Y., Lin, K., and Nie, S. 2002. The effect of fibrillar A β 1-40 on membrane fluidity and permeability. Protein Pept. Lett. 9: 173-178.